Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Trial to Evaluate a Routine Full Anticoagulation Strategy in Patients With Coronavirus (COVID-19) - COALIZAO ACTION Trial

NCT04394377 is registered in ClinicalTrials.gov with Brazilian Clinical Research Institute as lead sponsor.

NCT NCT04394377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04394377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Trial to Evaluate a Routine Full Anticoagulation Strategy in Patients With Coronavirus (COVID-19) - COALIZAO ACTION Trial
Lead sponsor
Brazilian Clinical Research Institute
Phase
Phase 4
Overall status
Completed
Start date
June 21, 2020
Completion date
May 30, 2021
Enrollment
615 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection